Stockscreener 앱 받기
60.78
3.91%
-2.47
전일 마감가:
$63.25
열려 있는:
$63.85
하루 거래량:
557.18K
Relative Volume:
1.07
시가총액:
$2.58B
수익:
$17.39M
순이익/손실:
$-135.89M
주가수익비율:
-13.10
EPS:
-4.64
순현금흐름:
$-123.00M
1주 성능:
-5.94%
1개월 성능:
-19.74%
6개월 성능:
+15.29%
1년 성능:
+16.37%
1일 변동 폭
$60.54
$64.04
1주일 범위
$60.54
$67.70
52주 변동 폭
$38.51
$85.25
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
명칭
Tarsus Pharmaceuticals Inc
전화
(949) 409-9820
주소
15440 LAGUNA CANYON ROAD, IRVINE
Compare TARS vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
60.78 | 2.68B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-20 | 개시 | Mizuho | Outperform |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-27 | 재개 | H.C. Wainwright | Buy |
| 2023-11-20 | 개시 | Goldman | Neutral |
| 2023-07-18 | 개시 | William Blair | Outperform |
| 2023-05-18 | 개시 | Guggenheim | Buy |
| 2022-08-01 | 개시 | Barclays | Overweight |
| 2021-12-21 | 개시 | H.C. Wainwright | Buy |
| 2021-11-23 | 개시 | Oppenheimer | Outperform |
| 2020-11-10 | 개시 | BofA Securities | Buy |
| 2020-11-10 | 개시 | Jefferies | Buy |
| 2020-11-10 | 개시 | Ladenburg Thalmann | Buy |
| 2020-11-10 | 개시 | Raymond James | Strong Buy |
모두보기
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
What is the long term forecast for Tarsus Pharmaceuticals Inc. stock2025 Price Momentum & Daily Volume Surge Trade Alerts - mfd.ru
Will Tarsus Pharmaceuticals Inc. be affected by tariffsPortfolio Performance Summary & AI Forecasted Stock Moves - mfd.ru
Will Tarsus Pharmaceuticals Inc. benefit from rising consumer demandShort Setup & Capital Protection Trade Alerts - mfd.ru
Can Tarsus Pharmaceuticals Inc. maintain sales growthStop Loss & Weekly Breakout Opportunity Watchlist - mfd.ru
Why is Tarsus Pharmaceuticals Inc stock going down2025 Growth vs Value & Consistent Profit Trade Alerts - baoquankhu1.vn
Will Tarsus Pharmaceuticals Inc. stock recover faster than market2025 Trading Volume Trends & Long-Term Capital Growth Strategies - mfd.ru
Panic Selling: Is Tarsus Pharmaceuticals Inc still a buy after recent gainsJuly 2025 Levels & Reliable Intraday Trade Plans - baoquankhu1.vn
Federated Hermes Inc. Has $905,000 Stock Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Shareholders Should Be Pleased With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Price - simplywall.st
Liquidity Mapping Around (TARS) Price Events - Stock Traders Daily
Dow Update: Does Tarsus Pharmaceuticals Inc have declining or rising EPS2025 EndofYear Setup & Daily Profit Focused Screening - baoquankhu1.vn
Stocks to watch: Tarsus Pharmaceuticals sees RS rating rise to 81 - MSN
Lisanti Capital Growth LLC Has $2.56 Million Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus prices $125M stock offering - MSN
Does Tarsus Pharmaceuticals Inc have declining or rising EPSBuy Signal & Intraday High Probability Setup Alerts - baoquankhu1.vn
Will Tarsus Pharmaceuticals Inc. benefit from green energy policies2025 Key Highlights & High Win Rate Trade Alerts - mfd.ru
Investors Still Waiting For A Pull Back In Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - 富途牛牛
Tarsus Pharmaceuticals Shares Show Resilience Amid Market Pressure - AD HOC NEWS
Hussman Strategic Advisors Inc. Purchases Shares of 31,500 Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Volume Report: How does DMC Global Inc correlate with Nasdaq2025 Major Catalysts & Weekly Top Gainers Trade List - baoquankhu1.vn
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Universal Beteiligungs und Servicegesellschaft mbH Has $5.44 Million Stake in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Down 16.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Tarsus Pharmaceuticals (TARS) - Finviz
SG Americas Securities LLC Sells 27,833 Shares of Tarsus Pharmaceuticals, Inc. $TARS - Defense World
Why (TARS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Tarsus Pharmaceuticals, Inc. $TARS Shares Purchased by Jennison Associates LLC - MarketBeat
Portfolio Update: Does Tarsus Pharmaceuticals Inc have declining or rising EPSQuarterly Earnings Report & Long-Term Growth Plans - baoquankhu1.vn
Relative Strength Alert For Tarsus Pharmaceuticals - Nasdaq
Does Tarsus Pharmaceuticals (NASDAQ:TARS) Have A Healthy Balance Sheet? - simplywall.st
While shareholders of Tarsus Pharmaceuticals (NASDAQ:TARS) are in the black over 3 years, those who bought a week ago aren't so fortunate - Yahoo Finance
Understanding Momentum Shifts in (TARS) - Stock Traders Daily
BMRN or TARS: Which Is the Better Value Stock Right Now? - Yahoo Finance
Aug PostEarnings: Why Tarsus Pharmaceuticals Inc. stock could rally in 20252025 Bull vs Bear & AI Based Trade Execution Alerts - Bộ Nội Vụ
Tarsus Pharmaceuticals, Inc. Publishes Corporate Presentation on Eye Care Innovations - TradingView — Track All Markets
What analyst consensus says on Tarsus Pharmaceuticals Inc. stockStop Loss & Smart Allocation Stock Tips - Улправда
Why Tarsus Pharmaceuticals Inc. stock is trending among retail tradersPortfolio Value Report & Real-Time Stock Entry Alerts - Улправда
Growth Recap: Why Tarsus Pharmaceuticals Inc. stock is trending among retail tradersMarket Activity Summary & Free Long-Term Investment Growth Plans - Улправда
Will Tarsus Pharmaceuticals Inc. stock outperform tech sector in 2025Portfolio Gains Summary & Free Real-Time Volume Trigger Notifications - Улправда
Tarsus Pharmaceuticals (NASDAQ:TARS) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway - 富途牛牛
Insider Sell Alert: Dianne Whitfield Sells 15,565 Shares of Tarsus Pharmaceuticals Inc (TARS) - GuruFocus
Avoiding Lag: Real-Time Signals in (TARS) Movement - Stock Traders Daily
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) CEO Bobak Azamian Sells 6,000 Shares - MarketBeat
Tarsus Pharmaceuticals Insider Sold Shares Worth $495,089, According to a Recent SEC Filing - MarketScreener
Tarsus Pharmaceuticals (TARS) Investor Outlook: Strong Buy Ratings and Promising Revenue Growth in Biotech - DirectorsTalk Interviews
Will Tarsus Pharmaceuticals Inc. stock split attract more investorsDividend Cut Warnings & Low Risk Investment Plans - bollywoodhelpline.com
Tarsus to Participate at the Bank of America 2023 Healthcare Conference - 富途牛牛
240,020 Shares in Tarsus Pharmaceuticals, Inc. $TARS Purchased by Capricorn Fund Managers Ltd - MarketBeat
Tarsus Pharmaceuticals Earnings Notes - Trefis
Market Sentiment Around Loss-Making Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - simplywall.st
Tarsus Pharmaceuticals Inc (TARS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.12%
0.87%
자본화:
|
볼륨(24시간):